EssilorLuxottica Shares Gain Momentum on AI Eyewear and Analyst Upgrade

Shares of EssilorLuxottica are attracting significant investor interest following a major analyst upgrade and the successful launch of its next-generation smart eyewear developed in partnership with Meta Platforms Inc. These developments are expected to accelerate the company’s growth trajectory in the burgeoning tech-infused eyewear market.

Strategic Partnership Yields New Product Launches

The collaboration with Meta Platforms has culminated in the introduction of two advanced AI-powered eyewear models, reinforcing EssilorLuxottica’s position at the intersection of optical care and cutting-edge technology. The new products, unveiled on September 18, are:

• Meta Ray-Ban Display: Priced from $799 and available from September 30. This model incorporates a miniature display within the right lens and is controlled via hand gestures using a companion wristband.
• Oakley Meta Vanguard: Aimed at athletes, this model will be available from October 21 starting at $499. It provides real-time performance metrics, is equipped with a 12MP camera, and offers up to nine hours of battery life.

Market response to this expansion has been positive. RBC Capital Markets issued a favorable assessment of the new lineup, projecting a substantial boost to the company’s fourth-quarter revenue.

Should investors sell immediately? Or is it worth buying Essilor International?

Analyst Sentiment Mixed but Upgraded

The investment firm Rothschild Redburn provided a significant boost to market sentiment on September 17 by raising its rating on EssilorLuxottica from “Neutral” to “Buy.” In a decisive move, the analysts also lifted their price target from €235 to €320, implying a potential 21% upside. They justified this upgrade by citing the company’s “unparalleled position in the eye care market” and its strategic expansion into high-growth areas like myopia management, audiology, and smart glasses.

Conversely, HSBC maintained a more cautious stance, reiterating its “Hold” recommendation with an unchanged price target of €300. While the bank acknowledged encouraging prospects for the company’s innovative products, it also pointed to potential risks associated with acquisitions outside of its core business.

Market Performance Reflects Product Optimism

Trading activity immediately following the product announcements indicates strong investor confidence. On September 18, the company’s share price advanced by 1.7% to close at €274.50. The stock experienced a slight correction the following day, dipping by 0.29% to settle at €273.70. The consistent stream of innovations in the AI eyewear segment continues to solidify the group’s leadership in blending technology with optical health.